WAVE Life Sciences (WVE) Reiterated at Overweight by Cantor Fitzgerald on WVE-006 Data

May 19, 2026 6:56 AM

Cantor Fitzgerald analyst Steve Seedhouse reiterated an Overweight rating and $13.00 price target on WAVE Life Sciences (NASDAQ: WVE).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found